Otis Brawley

Last updated

Otis Webb Brawley
Nationality American
Alma mater University of Chicago, Pritzker School of Medicine
Known forWork on cancer
AwardsKey to St. Bernard Parish, Georgia Cancer Coalition Scholar, Member of the National Academy of Medicine
Scientific career
Fields Oncology and Epidemiology
InstitutionsJohns Hopkins University

Otis Webb Brawley is an American physician and the Bloomberg Distinguished Professor of Oncology and Epidemiology at Johns Hopkins University. He served as Chief Medical and Scientific Officer and Executive Vice President of the American Cancer Society from July 2007 to November 2018. He is board certified in internal medicine and medical oncology and is a Master of the American College of Physicians, Fellow of the American Society of Clinical Oncology, and a Fellow of the American College of Epidemiology. He is a member of the Institute of Medicine now known as the National Academy of Medicine.

Contents

Biography

Brawley is a graduate of University of Chicago, Pritzker School of Medicine. He completed a residency in internal medicine at University Hospitals of Cleveland, Case-Western Reserve University, and a fellowship in medical oncology at the National Cancer Institute. As the chief medical and scientific officer and executive vice president of the American Cancer Society, Brawley is responsible for promoting the goals of cancer prevention, early detection, and quality treatment through cancer research and education. He is Professor of haematology, medical oncology, medicine and epidemiology at Emory University. He is also a medical consultant to the Cable News Network (CNN). [1] From 2001 to 2007, he was medical director of the Georgia Cancer Center for Excellence at Grady Memorial Hospital in Atlanta, and deputy director for cancer control at the Winship Cancer Institute at Emory University. He has also previously served as a member of the Society's Prostate Cancer Committee, co-chaired the U.S. Surgeon General's Task Force on Cancer Health Disparities, and filled a variety of positions at the National Cancer Institute (NCI), most recently serving as assistant director. Brawley serves on the Board of Regents of the Uniformed Services University of the Health Sciences. He has served as a member of the Food and Drug Administration Oncologic Drug Advisory Committee, the Centers for Disease Control and Prevention Breast and Cervical Cancer Early Detection and Control Advisory Committee and chaired the NIH Consensus Panel on the Treatment of Sickle Cell Disease. Among numerous other awards, he was a Georgia Cancer Coalition Scholar and received the Key to St. Bernard Parish for his work in the U.S. Public Health Service in the aftermath of Hurricane Katrina. In 2011, Brawley joined the International Prevention Research Institute as Senior Research Fellow. [2] In 2022, he was listed on STAT's inaugural STATUS List, "the most definitive and consequential accounting of important and impactful leaders in the life sciences." [3] [4]

Brawley has published more than 200 scientific articles [5] and he has written a book, How We Do Harm: A Doctor Breaks Ranks About Being Sick in America. [6]

Brawley works to reduce overscreening of medical conditions. [7]

Awards

Brawley's awards include:

Books

Otis Brawley wrote the 2012 book, How We Do Harm: A Doctor Breaks Ranks About Being Sick in America https://www.amazon.com/How-We-Do-Harm-America/dp/1250015766/?_encoding=UTF8&pd_rd_w=0RmGb&content-id=amzn1.sym.a725c7b8-b047-4210-9584-5391d2d91b93%3Aamzn1.symc.d10b1e54-47e4-4b2a-b42d-92fe6ebbe579&pf_rd_p=a725c7b8-b047-4210-9584-5391d2d91b93&pf_rd_r=Y1PABF05XQ18QMSW5QN4&pd_rd_wg=saZrT&pd_rd_r=5ee805c3-4321-442c-82b6-262ac27a32f8&ref_=pd_hp_d_atf_ci_mcx_mr_hp_atf_m

Publications

Brawley has more than 30,000 citations in Google Scholar and an h-index of 73. [17]

Highly Cited Articles (more than 1000 citations)

Related Research Articles

<span class="mw-page-title-main">Vincent T. DeVita</span> American oncologist and academic

Vincent Theodore DeVita Jr. is the Amy and Joseph Perella Professor of Medicine at Yale Cancer Center, and a Professor of Epidemiology and Public Health. He directed the Yale Cancer Center from 1993 to 2003. He has been president of the board of directors of the American Cancer Society (2012-2013). He is internationally recognized as a pioneer in the field of oncology for his work on combination-chemotherapy treatments.

<span class="mw-page-title-main">Chandler Park</span> American physician

Chandler Park is an American physician, medical journalist, and clinical researcher. In June 2021, his cancer research was published in prominent medical journals including the New England Journal of Medicine and Journal of Clinical Oncology. Park also contributes regularly as an expert physician for popular newspapers and magazines such as Newsweek, Reader's Digest, U.S. News & World Report, The Exponent-Telegram, College of St. Scholastica, and Medscape and writes medical news for Doximity.

<span class="mw-page-title-main">Emil Frei</span> American physician and oncologist

Emil "Tom" Frei III was an American physician and oncologist. He was the former director and former physician-in-chief of the Dana–Farber Cancer Institute in Boston, Massachusetts. He was also the Richard and Susan Smith Distinguished Professor of Medicine at Harvard Medical School.

Graham Andrew Colditz MD, DrPH is an Australian chronic disease epidemiologist. He is the inaugural Niess-Gain Professor at Washington University School of Medicine, where he is associate director for Prevention and Control at the Alvin J. Siteman Cancer Center. He directs the Master of Population Health Science at Washington University School of Medicine. During medical training he was excited by the potential for prevention of chronic diseases. With encouragement from mentors he pursued training in the US as it was routine for academics in Australia to obtain overseas training at that time. He is internationally recognized for leadership in cancer prevention, and is often interviewed by media for input on this topic. With members of Cancer Prevention and Control at Siteman, he blogs on issues relating to cancer prevention and screening. According to Google Scholar statistics, Colditz has a h-index of more than 300.

<span class="mw-page-title-main">Joseph F. Fraumeni Jr.</span> American physician and cancer researcher

Joseph F. Fraumeni Jr. is an American physician and cancer researcher. Born in Boston, he received an A.B. from Harvard College, an M.D. from Duke University, and an M.Sc. in epidemiology from the Harvard School of Public Health. He completed his medical residency at Johns Hopkins Hospital and Memorial Sloan Kettering Cancer Center. He then joined the National Cancer Institute at the National Institutes of Health in 1962 as a commissioned officer of the U.S. Public Health Service, becoming the founding Director of the Division of Cancer Epidemiology and Genetics in 1995. He stepped down from this position in 2012 to become a senior investigator and advisor to the National Cancer Institute.

Paolo Boffetta is an Italian epidemiologist. He is doing research on cancer and other chronic diseases, where he contributed to the understanding of the role of occupation, environment, alcohol, smoking and nutrition in disease development.

<span class="mw-page-title-main">Charles Sawyers</span> American physician-scientist (born 1959)

Charles L. Sawyers is a Howard Hughes Medical Institute (HHMI) investigator who holds the Marie-Josée and Henry R. Kravis Chair of the Human Oncology and Pathogenesis Program (HOPP) at Memorial Sloan Kettering Cancer Center (MSK). HOPP is a program created in 2006 that comprises researchers from many disciplines to bridge clinical and laboratory discoveries.

<span class="mw-page-title-main">Olufunmilayo Olopade</span> Nigerian physician

Olufunmilayo I. Olopade born in the year 1957, is a Nigerian hematology oncologist, Associate Dean for Global Health and Walter L. Palmer, Distinguished Service Professor in Medicine and Human Genetics at the University of Chicago. She also serves as director of the University of Chicago Hospital's Cancer Risk Clinic.

William K. Oh, is an American medical oncologist, academic and industry leader and expert in the management of genitourinary malignancies, including prostate, renal, bladder and testicular cancers.

Alan D. D'Andrea is an American cancer researcher and the Fuller American Cancer Society Professor of Radiation Oncology at Harvard Medical School. D'Andrea's research at the Dana Farber Cancer Institute focuses on chromosome instability and cancer susceptibility. He is currently the director of the Center for DNA Damage and Repair and the director of the Susan F. Smith Center for Women's Cancer.

Owen Witte is an American physician-scientist at the University of California, Los Angeles. He is a University Professor of microbiology, immunology and molecular genetics in the David Geffen School of Medicine at UCLA, founding director emeritus of the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, and the UC Regents’ David Saxon Presidential Chair in developmental immunology (1989–present). Witte is also a Howard Hughes Medical Institute investigator (1986–2016) and a member of the President's Cancer Panel, the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences, and the Cancer Research Academy of the AACR. He serves on numerous editorial boards and scientific advisory boards for academic centers and biotechnology companies.

<span class="mw-page-title-main">Carl H. June</span> American immunologist and oncologist

Carl H. June is an American immunologist and oncologist. He is currently the Richard W. Vague Professor in Immunotherapy in the Department of Pathology and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania. He is most well known for his research on T cell therapies for the treatment of several forms of cancers. In 2020 he was elected to the American Philosophical Society.

Scott M. Lippman is the former Director of Moores Cancer Center at the University of California, San Diego and current Professor of Medicine at UC San Diego School of Medicine.

<span class="mw-page-title-main">Daniel Von Hoff</span> American oncologist

Daniel D. Von Hoff is the physician in chief and director of translational research at Translational Genomics Research Institute (TGen), and current Virginia G. Piper Distinguished Chair for Innovative Cancer Research at HonorHealth Clinical Research Institute. He is also a professor of medicine at the Mayo Clinic and medical director of research as well as chief scientific officer at US Oncology. He is most notable for his work in targeted therapies for the treatment of cancer. He led the development of gemcitabine, and has several drugs in development.

<span class="mw-page-title-main">Curtis C. Harris</span> American cancer researcher

Curtis. C. Harris is the head of the Molecular Genetics and Carcinogenesis Section and chief of the Laboratory of Human Carcinogenesis at the Center for Cancer Research of the National Cancer Institute, NIH.

Joseph Rocco Bertino was an American researcher in the cancer pharmacology program at Rutgers Cancer Institute of New Jersey and professor of medicine and pharmacology at the Robert Wood Johnson Medical School in New Jersey. His research focused on the treatment of lymphoma.

<span class="mw-page-title-main">Lucile Adams-Campbell</span> American epidemiologist

Lucile L. Adams-Campbell is the first African-American woman to receive a PhD in epidemiology in the United States. She serves as the Professor of Oncology at Lombardi Comprehensive Cancer Center and associate director for Minority Health at the Georgetown University Medical Center. She is a Fellow of the National Academy of Medicine, and the Washington DC Hall of Fame.

Roy S. Herbst is an American oncologist who is the Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, and Associate Director for Translational Research at Yale Cancer Center and Yale School of Medicine in New Haven, Connecticut.

Philip Greenberg is a professor of medicine, oncology, and immunology at the University of Washington and head of program in immunology at the Fred Hutchinson Cancer Research Center. His research is centered around T cell biology and therapeutic cell therapies. He is a co-founder of Juno Therapeutics.

Mitchell H. Gail is an American physician-scientist and biostatistician. He is a distinguished investigator at the National Cancer Institute.

References

  1. ↑ Otis Brawley, Medical Consultant to the CNN
  2. ↑ Otis Brawley at iPRI Archived 24 March 2012 at the Wayback Machine
  3. 1 2 "Washington City Paper - Press Releases". Washington City Paper. 11 February 2022. Retrieved 21 March 2022.
  4. ↑ "BDP Otis Brawley named by STAT as one of the country's most influential science thought leaders". The Hub. 1 March 2022. Retrieved 21 March 2022.
  5. ↑ Otis Brawley's publications in PubMed
  6. ↑ "How We Do Harm", Kirkus Reviews, 28 November 2011.
  7. ↑ Lenzer, Jeanne (2016). "Otis Brawley—one of the first to question the value of screening". BMJ. 353: i2301. doi:10.1136/bmj.i2301. ISSN   1756-1833. PMID   27117310. S2CID   38917899.
  8. ↑ "Atlanta physician honored with Distinguished Service Award". American Medical Association. Retrieved 28 April 2021.
  9. ↑ "Otis W. Brawley, SB'81, MD'85, to deliver Class Day address during Convocation". University of Chicago News. Retrieved 28 April 2021.
  10. ↑ "2018 Annual Report - Maryland State Council on Cancer Control" (PDF). Maryland Department of Health. Retrieved 28 April 2021.
  11. ↑ "Otis W. Brawley, M.D. Elected to National Academy of Medicine". American Cancer Society MediaRoom. Retrieved 28 April 2021.
  12. ↑ "Mastership | Awards, Masterships & Competitions | ACP". www.acponline.org. Retrieved 28 April 2021.
  13. ↑ "Otis W. Brawley, MD | CEO Roundtable on Cancer". www.ceoroundtableoncancer.org. Retrieved 28 April 2021.
  14. ↑ "AACR-MICR Jane Cooke Wright Lectureship | Awards | AACR".
  15. ↑ "Otis W. Brawley, MD, MACP, FASCO". ASCO. Retrieved 28 April 2021.
  16. ↑ "Otis Brawley". The Forum at Harvard T. H. Chan School of Public Health. 10 February 2017. Retrieved 28 April 2021.
  17. ↑ "Otis Brawley". scholar.google.com. Retrieved 11 May 2021.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.